25.50 USD
▼+0.10-6.73%
盘后 28.38 +3.80%
2026-08-03
市值
$657.36M
市盈率
—
EPS
-145.28
股息率
—
52 周区间
7.20 – 37.90
成交量
651.93K
Beta
-0.32
目标价
54.75
52W 低 7.2052W 高 37.90
价格走势
公司简介
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early ...